Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Market Cap	21.30B +33.4%
Revenue (ttm)	2.03B +11.4%
Net Income	725.75M +6.8%
EPS	13.31 +6.8%
Shares Out	54.46M
PE Ratio	29.38
Forward PE	n/a
Dividend	11.60 (2.96%)
Ex-Dividend Date	Mar 31, 2026

Volume	2,562
Average Volume	7,701
Open	391.00
Previous Close	391.00
Day's Range	391.00 - 391.00
52-Week Range	322.00 - 501.00
Beta	-0.18
RSI	50.21
Earnings Date	May 12, 2026

About Sunmax Biotechnology

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4728

Financial Performance

In 2025, Sunmax Biotechnology's revenue was 2.03 billion, an increase of 11.45% compared to the previous year's 1.82 billion. Earnings were 725.75 million, an increase of 6.82%.